Literature DB >> 28583851

β-hydroxybutyrate alleviates depressive behaviors in mice possibly by increasing the histone3-lysine9-β-hydroxybutyrylation.

Li Chen1, Zhigang Miao2, Xingshun Xu3.   

Abstract

Epigenetics regulation has been considered a mechanistic interface between environmental stress stimuli and altered functioning of underlying gene network. Metabolite changes in vivo after stress contribute to histone modification. Histone3-lysine9-β-hydroxybutyrylation (H3k9bhb), a novel histone modification mark induced by β-hydroxybutyrate, may participate in the development of depression. To examine the role of H3k9bhb in depression, experiments were performed on mice and cells. H3k9bhb were reduced in the brain of depressive mice. Exogenous β-hydroxybutyrate ameliorated depressive behaviors and reversed the reduction of H3K9bhb and BDNF. We showed that H3k9bhb played a role in depression, and firstly linked BHB and BDNF via H3k9bhb. Our findings emphasized the crucial role of metabolic regulation on epigenetics in depression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Depression; Epigenetic; Hydroxybutyrylation; β-hydroxybutyrate

Mesh:

Substances:

Year:  2017        PMID: 28583851     DOI: 10.1016/j.bbrc.2017.05.184

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  1,3-Butanediol attenuates hypertension and suppresses kidney injury in female rats.

Authors:  Jeanne A Ishimwe; Michael R Garrett; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-08

Review 2.  Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.

Authors:  Wen Li; Feifei Li; Xia Zhang; Hui-Kuan Lin; Chuan Xu
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

3.  RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes.

Authors:  Philip Mm Ruppert; Lei Deng; Guido Jej Hooiveld; Roland Wj Hangelbroek; Anja Zeigerer; Sander Kersten
Journal:  Life Sci Alliance       Date:  2021-08-18

4.  Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice.

Authors:  Tianyao Liu; Yuanyuan Ma; Ruiyu Zhang; Hongyu Zhong; Lian Wang; Jinghui Zhao; Ling Yang; Xiaotang Fan
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

Review 5.  Exercise Factors Released by the Liver, Muscle, and Bones Have Promising Therapeutic Potential for Stroke.

Authors:  Joseph S Stephan; Sama F Sleiman
Journal:  Front Neurol       Date:  2021-05-24       Impact factor: 4.003

6.  Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine.

Authors:  Norihiro Saito; Masamichi Itoga; Satoko Minakawa; Hiroyuki Kayaba
Journal:  Int J Gen Med       Date:  2021-05-10

Review 7.  Metabolic reprogramming and epigenetic modifications on the path to cancer.

Authors:  Linchong Sun; Huafeng Zhang; Ping Gao
Journal:  Protein Cell       Date:  2021-05-29       Impact factor: 15.328

8.  Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics.

Authors:  Liam J Hawkins; Rasha Al-Attar; Kenneth B Storey
Journal:  PeerJ       Date:  2018-06-15       Impact factor: 2.984

Review 9.  Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Authors:  Zsolt Kovács; Dominic P D'Agostino; David Diamond; Mark S Kindy; Christopher Rogers; Csilla Ari
Journal:  Front Psychiatry       Date:  2019-05-23       Impact factor: 4.157

10.  Effect of A Very Low-Calorie Ketogenic Diet on Food and Alcohol Cravings, Physical and Sexual Activity, Sleep Disturbances, and Quality of Life in Obese Patients.

Authors:  Ana I Castro; Diego Gomez-Arbelaez; Ana B Crujeiras; Roser Granero; Zaida Aguera; Susana Jimenez-Murcia; Ignacio Sajoux; Patricio Lopez-Jaramillo; Fernando Fernandez-Aranda; Felipe F Casanueva
Journal:  Nutrients       Date:  2018-09-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.